Best Transcatheter Aortic Valve Implantation Hospitals in Israel

Choosing Rabin Medical Center for Transcatheter Aortic Valve Implantation gives patients access to experienced structural heart specialists, advanced imaging technology, and comprehensive cardiac care. Established in 1996, the JCI hospital in Petah Tikva, Israel has 1300 beds and provides specialized valve replacement services.

Transcatheter Aortic Valve Implantation (TAVI) may be considered for patients with severe aortic stenosis when valve replacement is indicated. Unlike conventional open-heart valve replacement, TAVI uses a catheter to deliver and implant a replacement valve within the patient's existing aortic valve. Doctors evaluate the severity of valve disease, symptoms, vascular anatomy, heart function, and other clinical factors before treatment. Following implantation, patients are monitored for valve performance, rhythm changes, vascular complications, and overall recovery.

At Sheba Medical Center, Transcatheter Aortic Valve Implantation is performed using advanced catheter-based valve replacement techniques and personalised treatment plans based on the patient's cardiovascular condition. Established in 1948, this JCI hospital in Ramat Gan, Israel has 1900 beds and provides comprehensive structural heart care.

Transcatheter Aortic Valve Implantation (TAVI) may be recommended for selected patients with severe aortic valve disease, particularly severe symptomatic aortic stenosis. The procedure involves advancing a collapsible replacement valve through a catheter and deploying it within the diseased native aortic valve. Detailed pre-procedure evaluation, including echocardiography and CT angiography, helps determine the valve size, access route, and procedural approach. Regular follow-up is important to monitor valve function and cardiovascular recovery.

Herzliya Medical Center offers advanced Transcatheter Aortic Valve Implantation (TAVI) using modern structural heart intervention techniques and internationally accepted treatment protocols. Established in 1983, the hospital is located in Herzliya, Israel and has 120 beds, providing comprehensive cardiovascular care for local and international patients.

Transcatheter Aortic Valve Implantation is a minimally invasive procedure used to replace a diseased aortic valve, most commonly in patients with severe aortic stenosis. During the procedure, a replacement valve is delivered through a catheter, usually via an artery in the groin, and positioned within the existing valve. Before treatment, doctors perform echocardiography, CT imaging, and other cardiac assessments to evaluate valve anatomy and determine suitability. Post-procedure monitoring helps assess valve function and recovery.

At Assuta Hospital, Transcatheter Aortic Valve Implantation is performed using advanced catheter-based valve replacement techniques and personalised treatment plans based on the patient's cardiovascular condition. Established in 1934, this JCI hospital in Tel Aviv, Israel has 300 beds and provides comprehensive structural heart care.

Transcatheter Aortic Valve Implantation (TAVI) may be recommended for selected patients with severe aortic valve disease, particularly severe symptomatic aortic stenosis. The procedure involves advancing a collapsible replacement valve through a catheter and deploying it within the diseased native aortic valve. Detailed pre-procedure evaluation, including echocardiography and CT angiography, helps determine the valve size, access route, and procedural approach. Regular follow-up is important to monitor valve function and cardiovascular recovery.

Tel Aviv Sourasky Medical Center -Ichilov Hospital is a trusted healthcare provider for Transcatheter Aortic Valve Implantation, offering specialised transcatheter valve interventions supported by experienced interventional cardiologists and cardiac surgeons, and backed by modern medical infrastructure. Established in 1963, the JCI hospital is situated in Tel Aviv, Israel and has 1500 beds.

Transcatheter Aortic Valve Implantation provides a minimally invasive alternative to conventional surgical aortic valve replacement for appropriately selected patients. It is primarily used to treat severe aortic stenosis, in which narrowing of the valve restricts blood flow from the heart to the body. A replacement biological valve is delivered through a catheter and expanded inside the diseased valve. Comprehensive cardiac imaging and multidisciplinary assessment are performed before the procedure to determine eligibility and plan treatment.